humanized anti-GPCR antibody (Domain Therapeutics)

N/A

Report date: 2025/01/26 16:22:38

Base Information

Drug Namehumanized anti-GPCR antibody (Domain Therapeutics)
Drug Alias NameTreg modulator (Domain Therapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionG-protein coupled receptor antagonists
TargetsG-protein coupled receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDomain Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesDomain Therapeutics SA
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A